| 000 | 01587 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515104843.0 | ||
| 264 | 0 | _c20080215 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a1574-8898 | ||
| 024 | 7 |
_a10.2174/157488906778773706 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartynyuk, Anatoly E | |
| 245 | 0 | 0 |
_aHalogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders. _h[electronic resource] |
| 260 |
_bRecent patents on CNS drug discovery _cNov 2006 |
||
| 300 |
_a261-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aBrain Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxyl Radical |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aSeubert, Christoph N | |
| 700 | 1 | _aYarotskyy, Viktor | |
| 700 | 1 | _aGlushakov, Alexander V | |
| 700 | 1 | _aGravenstein, Nikolaus | |
| 700 | 1 | _aSumners, Colin | |
| 700 | 1 | _aDennis, Donn M | |
| 773 | 0 |
_tRecent patents on CNS drug discovery _gvol. 1 _gno. 3 _gp. 261-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/157488906778773706 _zAvailable from publisher's website |
| 999 |
_c17728436 _d17728436 |
||